(Q40356071)

English

Combination of enoxaparin and fibroblast growth factor-1 increases myocardial blood flow and capillary density after myocardial infarction in rabbits

scientific article published on July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Combination of enoxaparin and fibroblast growth factor-1 increases myocardial blood flow and capillary density after myocardial infarction in rabbits (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Andrea Geist

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jana Marx

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Silke Müller

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Uzan

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

B-U von Specht

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

J Haberstroh

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

European Surgical Research

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

191-198

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial

1 reference

https://api.crossref.org/works/10.1159%2F000087862

21 January 2018

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000087862

21 January 2018

Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events

1 reference

https://api.crossref.org/works/10.1159%2F000087862

21 January 2018

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

1 reference

https://api.crossref.org/works/10.1159%2F000087862

21 January 2018

Molecular mechanisms of coronary collateral vessel growth

1 reference

https://api.crossref.org/works/10.1159%2F000087862

21 January 2018

Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion

1 reference

https://api.crossref.org/works/10.1159%2F000087862

21 January 2018

Identifiers

10.1159/000087862

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40356071&oldid=1896030903"